This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Contraception
and you are
between 18 and 45
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will investigate the efficacy and safety of the monophasic combined oral contraceptive (COC) containing 2.5 mg NOMAC and 1.5 mg E2 in healthy fertile Indian women.

Provided treatments

  • Drug: Nomegestrol acetate (NOMAC)
  • Drug: Estradiol (E2)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01723579. The sponsor of the trial is Merck Sharp & Dohme Corp. and it is looking for 0 volunteers for the current phase.
Official trial title:
An Open-label, Multi-center Trial to Evaluate the Contraceptive Efficacy, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2) in Indian Women. Protocol MK-8175A-017-00